Tilray’s European pharmaceutical division, CC Pharma, has entered a strategic agreement with Smartway Pharmaceuticals to expand parallel import and specialist product supply across the UK. The collaboration will leverage Smartway’s established national distribution infrastructure alongside CC Pharma’s European procurement and GMP-certified manufacturing capacity.

An estimated £1 billion pharmaceutical segment forms the focus of this partnership, as Tilray seeks to accelerate access to medicinal products through pharmacy and hospital channels. The agreement positions the companies to improve supply reliability and expand reach within trusted healthcare networks.

CC Pharma and Smartway have collaborated since 2009 on cross-border pharmaceutical distribution, building on a decade of supply chain execution. Both companies will explore additional collaboration opportunities to support Tilray’s broader European medical expansion strategy and embed its medicinal cannabis products into the UK health system.